Your session is about to expire
← Back to Search
Ulipristal Acetate Tablets for Miscarriage
Study Summary
This trial will study if using ulipristal acetate with misoprostol is an effective and safe way to treat early pregnancy loss.
- Miscarriage
- Blighted Ovum
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2023 Phase 2 trial • 3 Patients • NCT05216952Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are patients currently being enrolled in this research study?
"According to the information available on clinicaltrials.gov, this trial is still looking for participants and was last edited on 6/9/2022. This study began recruiting patients on 5/11/2022 and plans to enroll 40 individuals at 4 medical centres."
What is the maximum dosage of Ulipristal Acetate Tablets that a patient should take?
"Ulipristal Acetate Tablets are currently being trialed in Phase 2, meaning that while there is some evidence of safety, none supports efficacy. Our team scores it a 2."
How many people are becoming a part of this research project?
"That is correct. The clinicaltrial.gov website indicates that this trial, which was first advertised on May 11th, 20212, is still recruiting patients. They are currently looking for 40 individuals who meet the study criteria and who are willing to participate at one of 4 sites."
Share this study with friends
Copy Link
Messenger